FDA Approvals in Oncology: October-December 2025
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
Author:
Cancer Research Catalyst Staff
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
The countdown to the new year is nearly upon us, but no need to count down to the last...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
In November, the AACR’s journal editors highlighted studies on sucralose limiting immunotherapy, benefits of caloric restriction, and more.
Shawn Lee, MD, PhD, an AACR-St. Baldrick’s Foundation Grantee, is working to personalize therapies for children with acute lymphoblastic...
In October 2025, AACR's journals editors highlighted studies on the anticancer function of an Alzheimer’s-related protein, small-molecule-drug conjugates, and...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
The 2025 AACR Journal Awards recognized outstanding researchers whose studies made in a significant impact in their respective domains.